Nuclear Medicine & Molecular Imaging Essentials
Session 1: Neuro, Head and Neck
The Evolving Role of PET/CT for Neuroendocrine Tumor Imaging | Daniel Pryma, MD |
PET Imaging of Alzheimer’s and Dementia | Ilya Nasrallah, MD, PhD |
Diagnosis & Therapy of Hyperthyroidism With Emphasis on Graves Disease | Bennett Greenspan, MD |
Thyroid Maliganacy and the ATA guidelines | Kenneth Burman, MD |
Thyroid Cancer Guidelines: A Nuclear Medicine Physician’s Case Based Review | Mark Tulchinsky, MD |
Session 2: Nuclear Cardiovascular Imaging
Best Practice Cardiac PET in 2017 | Manuel Cequeira, MD |
F-18 FDG PET/CT Imaging in Cardiac Sarcoidosis: What’s “Hot!” | Gary Dillehay, MD |
Cardiac CT and MRI – State of the Art | Charles White, MD |
MIBG Imaging in Heart Failure Management | Manuel Cequeira, MD |
Session 3: Practice Improvements
The Importance of Advocacy to the Nuclear Medicine Professional | Cindi Luckett-Gilbert, CNMT |
PET/CT Coding and Billing: “Am I Coding it Correctly?” | Gary Dillehay, MD |
Emergency Preparedness | Craig DeAtley, PA-C |
Session 4: Body Imaging
Integrating MRI and PSMA PET Imaging in Prostate Cancer | Peter Choyke, MD |
Hepatobiliary Scintigraphy in Chronic Abdominal Pain | Mark Tulchinsky, MD |
Glucose Metabolism Changes in Patients With Sepsis on FDG PET | Ghada Issa, MD |
The Role of 18F-FDG PET/CT in the Management of Gastric Cancers | Charles Marcus, MD |
Session 5: Perspectives and Procedures
18F-FDG-PET Imaging’s Contributions to Medicine | Abass Alavi, MD |
SNMMI Background and Agenda | Bennett Greenspan, MD |
Unusual Imaging Studies | Mark Crosthwaite, M.Ed, CNMT |
Reviews
There are no reviews yet.